Home/Filings/4/0001213900-23-075376
4//SEC Filing

Woody James N. 4

Accession 0001213900-23-075376

CIK 0001690080other

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 4:00 PM ET

Size

6.5 KB

Accession

0001213900-23-075376

Insider Transaction Report

Form 4
Period: 2023-09-04
Woody James N.
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-09-04+75,00075,000 total
    Exercise: $0.67Exp: 2033-09-04Common Stock (75,000 underlying)
Holdings
  • Common Stock

    41,888
Footnotes (2)
  • [F1]The Stock Options were granted to the Reporting Person pursuant to the Issuer's First Amended and Restated 2022 Omnibus Incentive Plan in consideration for services to be rendered as Chief Executive Officer. Exempt from Section 16(b) pursuant to Rule 16b-3.
  • [F2]The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.

Documents

1 file

Issuer

180 Life Sciences Corp.

CIK 0001690080

Entity typeother

Related Parties

1
  • filerCIK 0001553355

Filing Metadata

Form type
4
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:00 PM ET
Size
6.5 KB